Skip to main content

How ValueAct may bring an amicable approach to help boost margins at this Japanese medical device company

ValueAct Capital has a stake in Nihon Kohden. The firm's approach with Olympus and JSR may give an indication of how ValueAct will move forward from here.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.